Showing 1-10 of 1827 results for "".
- Mark A. Bechtel, MD, FAADhttps://practicaldermatology.com/profiles/mark-a-bechtel-md-faad/jVVKkW/
@PRACTICAL_DERM
https://practicaldermatology.com/topics/practice-management/practical_derm/21168/Rosacea: Choosing Among the Topical and Systemic Therapeutic Options
https://practicaldermatology.com/topics/general-topics/rosacea-choosing-among-the-topical-and-systemic-therapeutic-options/21706/As the field of therapies available for rosacea has expanded, clinicians must weigh the topical and oral treatment options on a case-by-case basisWhat Does Dermatology Need Right Now?
https://practicaldermatology.com/topics/practice-management/what-does-dermatology-need-right-now/23061/Experts weigh in on the pressing needs of the specialty today.Enhancing Treatment Adherence
https://practicaldermatology.com/topics/practice-management/enhancing-treatment-adherence/21083/Devising a strategy to engage patients in their treatment regimen for better results.- Project IMPACT from VisualDx Marks One Yearhttps://practicaldermatology.com/news/project-impact-from-visualdx-marks-one-year-1/2461123/VisualDx marks the one-year anniversary of
- Celotres Earns CE Mark Approval for Wound Healinghttps://practicaldermatology.com/news/20120504-celotres_earns_ce_mark_approval_for_wound_healing/2459808/European regulators have granted CE Mark approval for Celotres™ hydrogel scaffold from Halscion, Inc. The CE Mark approval was based on the results of a prospective, multi-center, randomized, same-patient controlled, European clinical trial evaluati
- ASA Honors Dr. Mark G. Lebwohl, Leo Pharmahttps://practicaldermatology.com/news/asa-honors-dr-mark-g-lebwohl-leo-pharma/2461652/Mark G. Lebwohl, MD and LEO Pharma received honors at the American Skin Association’s (ASA) annual Spring Gala, "We were proud to honor Dr. Mark Lebwohl and LEO Pharma for their dedication to the field of dermatology. Both honorees share in ASA
- DermTech Appoints Mark Aguillard as Chief Commercial Officerhttps://practicaldermatology.com/news/dermtech-appoints-mark-aguillard-as-chief-commercial-officer/2461990/Mark Aguillard is DermTech, Inc.’s chief commercial officer effective September 19, 2023. Mr. Aguillard will lead DermTech’s overall commercial strategy and execution. Prior to joining is DermTech, Mr. Aguillard served as the chief commercial officer of Epic
- Pulse Biosciences Scores CE Mark for CellFX Systemhttps://practicaldermatology.com/news/pulse-biosciences-scores-ce-mark-for-cellfx-system/2460666/Pulse Biosciences, Inc. received CE mark for the CellFXSystem. The Company can now proceed with its planned controlled launch of the CellFX System to medical practices within the European Union (EU) for the treatment of general dermatologic conditions, including sebaceous hyperplasia (S
- Prev
- Next